Trial · NCT04485195
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Conversion to sinus rhythm for a minimum duration of 30 minutes | During any time following randomization until 30 minutes past the completion of the drug infusion | Conversion to and maintenance of sinus rhythm for at least 30 minutes at any time following randomization until 30 minutes past the completion of the drug infusion. Heart rhythm will be determined by an electrocardiogram (ECG). |
| Secondary | Normal sinus rhythm | At the time of patient disposition (approximately 3 hours after arrival) | Being in normal sinus rhythm at the time of ED disposition (discharge or admission). Heart rhythm will be determined by an electrocardiogram (ECG). |
| Secondary | Patient disposition (admission or discharge) | At the time of patient admission or discharge (approximately 3 hours after arrival) | Whether the patient was discharged home or admitted to the hospital. |
| Secondary | Length of stay in ED | From time of arrival until time of discharge or admission (approximately 3 hours) | Length of stay in ED in minutes, from time of arrival to time of discharge or admission |
| Secondary | Time to discharge | From time of randomization until time of discharge or admission (approximately 3 hours) | Time to discharge in minutes, from time of randomization to time of discharge or admission |
| Secondary | Time to conversion | From time of infusion start until time of conversion to sinus rhythm (approximately 0 - 90 minutes) | Time to conversion to sinus rhythm in minutes, from time of start of study drug infusion |
| Secondary | Whether the patient required electrical cardioversion | From 30 minutes after the study drug infusion is completed. | Whether the patient required electrical cardioversion to restore normal sinus rhythm in the ED |
| Secondary | Adverse events | 0-12 hours | will be classified as serious or other, whether occurring 0-2 hours or 2-12 hours after infusion, whether infusion had to be halted or discontinued, or treatment required |
| Other | Maintenance of normal sinus rhythm | 30 days post discharge | Maintenance of normal sinus rhythm at 30 days after ED disposition, to be verified by hospital records, patient report, or by a smartphone application. |
| Other | Recurrence of acute AF | 30 days | Recurrence of acute atrial fibrillation requiring an emergency department visit |
| Other | Death | 30 days | within 30 days of ED disposition |
| Other | Stroke | 30 days | transient ischemic attack, myocardial infarction, or other thromboembolic event within 30 days of ED disposition |
| Other | Return to normal activities | 30 days | Return to normal daily activities measured in days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04485195/registered